Provided by Tiger Trade Technology Pte. Ltd.

Biohaven Pharmaceutical Holding Co Ltd.

13.85
+0.35002.59%
Volume:2.09M
Turnover:29.33M
Market Cap:2.08B
PE:-3.09
High:14.33
Open:13.60
Low:13.53
Close:13.50
52wk High:18.57
52wk Low:7.48
Shares:150.42M
Float Shares:117.99M
Volume Ratio:0.94
T/O Rate:1.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4800
EPS(LYR):-6.8648
ROE:-799.46%
ROA:-71.98%
PB:170.45
PE(LYR):-2.02

Loading ...

RBC Capital Sticks to Their Buy Rating for Biohaven Ltd. (BHVN)

TIPRANKS
·
Jun 25

Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX), Biohaven Ltd. (BHVN) and BioLife Solutions (BLFS)

TIPRANKS
·
Jun 25

Biohaven (BHVN) Is Up 22.2% After Advancing Multiple Immunology And Oncology Candidates To Pivotal Trials

Simply Wall St.
·
Jun 24

Analysts Are Bullish on These Healthcare Stocks: uniQure (QURE), Biohaven Ltd. (BHVN)

TIPRANKS
·
Jun 18

Acting US FDA chief meets with rare disease groups to mend fences

Reuters
·
Jun 04

Is Biohaven’s PKM2 and Autoimmune Pipeline Progress Altering The Investment Case For Biohaven (BHVN)?

Simply Wall St.
·
Jun 03

Biohaven Starts First Human Trial of BHV-8100 for Neurological, Retinal and Inflammatory Diseases

MT Newswires Live
·
Jun 01

Biohaven starts first-in-human Phase 1 trial of oral PKM2 modulator BHV-8100

Reuters
·
Jun 01

Analysts Are Bullish on These Healthcare Stocks: Biohaven Ltd. (BHVN), Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
May 30

Analysts Conflicted on These Healthcare Names: MannKind (MNKD), Biohaven Ltd. (BHVN) and Precision BioSciences (DTIL)

TIPRANKS
·
May 28

Canaccord Genuity Reaffirms Their Buy Rating on Biohaven Ltd. (BHVN)

TIPRANKS
·
May 28

Analysts Offer Insights on Healthcare Companies: Phreesia (PHR), McKesson (MCK) and Biohaven Ltd. (BHVN)

TIPRANKS
·
May 28

Biohaven says BHV-1300 cuts Graves’ disease autoantibodies by over 80% in Phase 1b study

Reuters
·
May 27

Biohaven Reports Positive Clinical Biomarker and Patient Data: First Mode and Trap Extracellular Protein Degraders Achieve Deep, Rapid, Selective Lowering of Disease-Driving Antibodies in Graves' Disease and Iga Nephropathy

THOMSON REUTERS
·
May 27

Biohaven (BHVN) Is Up 20.0% After Promising Opakalim Epilepsy Data Release Has The Bull Case Changed?

Simply Wall St.
·
May 27

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biohaven Ltd. (BHVN) and Immix Biopharma (IMMX)

TIPRANKS
·
May 27

Biohaven Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
May 27

Biohaven Gains After New Data From Epilepsy-Treatment Studies

Dow Jones
·
May 27

Biohaven reports data from selective Kv7.2/7.3 channel activator program

TIPRANKS
·
May 26

Biohaven says opakalim triples median time to second seizure day in idiopathic generalized epilepsy trial

Reuters
·
May 26